Delivery Order 36E79724D0005-36C77024F0047

Award Date 4/22/24

Potential Completion Date 10/15/24

Potential Value $3.4K

Funding Federal Agency

Veterans Integrated Service Network 7

Contracting Federal Agency

Veterans Integrated Service Network 15

Awardee

Glaxosmithkline, LLC FRHTPHMZMX47

Ultimate Awardee

Not listed

NAICS Category

325412 - Pharmaceutical Preparation Manufacturing

PSC Category

6505 - Drugs And Biologicals

Set-Aside Type

No Set-Aside Used

Federal Contract Vehicle

Not listed

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Durham, NC 27701, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This is a delivery order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for the pharmaceutical product FLUARIX TRIVALENT. The contract is a firm fixed price award with a potential value of $3,428.25 and a completion date of October 15, 2024. This appears to be a task order under a larger indefinite delivery vehicle contract, as Glaxosmithkline holds multiple federal contracts with the Department of Veterans Affairs, Centers for Disease Control and Prevention, and Defense Logistics Agency for the provision of seasonal influenza vaccines, vaccine storage and rotation services, and the antiviral medication zanamivir. The contract does not have a set-aside designation.

Generated 4/23/24, 4:11 PM